Principal Diana Manning will speak at at the New Jersey Institute for Continuing Legal Education (NJICLE) Program: Current Developments on the Admissibility of Expert Testimony in New Jersey: Daubert, In Re Accutane, Townsend v. Pierre and Beyond. The seminar will take place on February 21, 2019 at the Wilshire Grand in West Orange, NJ. On March 14, 2019, the seminar will be held at the New Jersey Law Center in New Brunswick, NJ.
About the Program
The New Jersey Supreme Court’s recent opinion in In Re Accutane is one of the most important evidence opinions by New Jersey Court in years. The case reviewed the standards for admissibility of expert testimony under New Jersey Law, and held that the US Supreme Court opinion in Daubert v Merrell Dow Pharmaceuticals, Inc., 509 US 579 (1993), is to guide the determination as to the reliability and admissibility of expert scientific testimony.
The panel will discuss the following:
- A review of case law leading up to In Re Accutane - Daubert, Kumho Tire, Hisenaj
- In Re Accutane - What did the Court hold? How does the holding change New Jersey law?
- What are the practical implications of the decision?
- Point-counter-point: what the decision means for defendants and what it means for plaintiffs
- Does the holding apply to all cases, or only cases with complex scientific or medical issues?
- Ethical implications when dealing with experts
For more information about the seminar, please click here.